Final answer:
Malignant hyperthermia (MH) is a rare but potentially life-threatening condition that can occur in response to certain medications used during general anesthesia.
Step-by-step explanation:
Malignant hyperthermia (MH) is estimated that MH affects approximately 1 in 10,000 to 1 in 50,000 people, making it relatively uncommon. However, the exact prevalence may vary depending on the population being studied.
MH is an inherited disorder, meaning that it can run in families. It is most commonly associated with mutations in the RYR1 gene, which is involved in regulating calcium levels in muscle cells. While MH can occur in individuals of all ages, it is most often seen in children and adolescents.
Early recognition and prompt treatment of MH are crucial to prevent complications. In suspected cases, anesthesia providers will administer specific medications and take other measures to stabilize the patient's condition. MH can be fatal if not treated promptly, but with appropriate management, the outcome is generally favorable.